TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8621129

Group type: EXPERIMENTAL
Intervention: Pregnant women (second trimester)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pregnant women (all trimesters)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pregnant women (second and third trimesters)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Controls (age-matched nonpregnant women)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pregnant women (third trimester)
Number of subjects: 103
Study: 1624646

Group type: EXPERIMENTAL
Intervention: Lofepramine
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 79
Study: 6095664

Group type: EXPERIMENTAL
Intervention: Today contraceptive sponge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diaphragm with spermicide
Number of subjects: 0
Study: 31243692

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (Rex group, n=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training with compression garment (Rex-Com group, n=30)
Number of subjects: 60
Study: 31278509

Group type: EXPERIMENTAL
Intervention: Distal Targeting System (DTS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Free-hand fluoroscopic guidance
Number of subjects: 36
Study: 28870208

Group type: EXPERIMENTAL
Intervention: 10 Top Tips (10TT)
Number of subjects: 537

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study: 26065353

Group type: EXPERIMENTAL
Intervention: Bandage contact lenses
Number of subjects: 32

Group type: COMPARATOR
Intervention: Pressure patching
Number of subjects: 32
Study: 23819991

Group type: EXPERIMENTAL
Intervention: Automated Neuropsychological Assessment Metrics 4 (ANAM4)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: CNS‐Vital Signs
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: CogState
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Immediate Post‐Concussion Assessment and Cognitive Test (ImPACT)
Number of subjects: 419
Study: 21780543

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol 50 microg
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol 25 microg
Number of subjects: 210

Group type: COMPARATOR
Intervention: Intracervical dinoprostone 0.5 mg
Number of subjects: 210
Study: 19454622

Group type: EXPERIMENTAL
Intervention: Progressive shoulder abduction loading intervention for 8 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group with weight of the arm supported during reaching tasks
Number of subjects: 14
Study: 16916334

Group type: EXPERIMENTAL
Intervention: Theophylline (100 mg b.i.d.)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 12776806

Group type: EXPERIMENTAL
Intervention: Test cyclosporine non-SMEDDS formulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cyclopsorine SMEDDS formulation
Number of subjects: 24
Study: 9887161

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (3 g [1200 mg of elemental calcium] daily)
Number of subjects: 930

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 930
Study: 7536831

Group type: EXPERIMENTAL
Intervention: Atole (163 kcal/682 kJ, 11.5 g protein per cup)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresco (59 kcal/247 kJ, 0 g protein per cup)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresco
Number of subjects: 0
Study: 2109473

Group type: EXPERIMENTAL
Intervention: Flumazenil 1 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (spontaneous awakening)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flumazenil 1 mg (Group B)
Number of subjects: 24
Study: 6993588

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G treatment
Number of subjects: 194
Study: 6849740

Group type: EXPERIMENTAL
Intervention: Alinidine 80 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hydralazine 50 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Alinidine 80 mg combined with Hydralazine 50 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg combined with Hydralazine 50 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31706311

Group type: EXPERIMENTAL
Intervention: Protein shake (PS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbohydrate shake (CS)
Number of subjects: 0
Study: 29419709

Group type: EXPERIMENTAL
Intervention: Single-session, clinic-based intervention promoting condom use
Number of subjects: 600
Study: 27810043

Group type: EXPERIMENTAL
Intervention: S-ICD
Number of subjects: 140

Group type: COMPARATOR
Intervention: TV-ICD
Number of subjects: 140
Study: 25377588

Group type: EXPERIMENTAL
Intervention: SASA! intervention
Number of subjects: 0
Study: 22536858

Group type: EXPERIMENTAL
Intervention: Standard topical lidocaine‐4% cream and 99mTc‐sulfur colloid injection
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Placebo cream and 99mTc‐sulfur colloid injection containing NaHCO3
Number of subjects: 140

Group type: COMPARATOR
Intervention: All African Americans
Number of subjects: 140
Study: 20074196

Group type: EXPERIMENTAL
Intervention: Audit and Feedback (A/F) intervention
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (no A/F intervention)
Number of subjects: 192
Study: 18823195

Group type: EXPERIMENTAL
Intervention: 4-dimensional maze navigation training
Number of subjects: 0
Study: 16075192

Group type: EXPERIMENTAL
Intervention: Parent training group
Number of subjects: 0

Group type: COMPARATOR
Intervention: General project participation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Declining families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parents accepting the offer of parent training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parents from disadvantaged areas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parents with children having higher levels of behavior problems
Number of subjects: 0
Study: 12609569

Group type: EXPERIMENTAL
Intervention: Univariate analysis of all patients
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Multivariate Cox model
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Subset multivariate analyses for limited-stage disease (LD-SCLC)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Subset multivariate analyses for extensive-stage disease (ED-SCLC)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 436
Study: 10503752

Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion (4 kcal x kg(-1) oral carbohydrate beverage)
Number of subjects: 15
Study: 9197016

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 152

Group type: COMPARATOR
Intervention: Acebutolol
Number of subjects: 152
Study: 1922863

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg P.O. the evening before surgery
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg P.O. the evening before surgery
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg I.M. 90 min before induction of anaesthesia
Number of subjects: 3

Group type: COMPARATOR
Intervention: No drug with H2‐antagonist effect
Number of subjects: 3
Study: 6128231

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 0.5 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31735161

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 100

Group type: COMPARATOR
Intervention: Beta-agonists
Number of subjects: 100
Study: 29771804

Group type: EXPERIMENTAL
Intervention: Preemptive analgesia (oral acetaminophen and gabapentin followed by intravenous ketamine and dexamethasone)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (oral placebos)
Number of subjects: 61
Study: 26406550

Group type: EXPERIMENTAL
Intervention: CT-guided (125)I brachytherapy (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Symptomatic and supportive treatments (group B)
Number of subjects: 72
Study: 24485467

Group type: EXPERIMENTAL
Intervention: Real 1-Hz rTMS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 24
Study: 22295819

Group type: EXPERIMENTAL
Intervention: Acupoint sticking therapy in dog days (group A)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Acupoint sticking therapy in non-dog days (group B)
Number of subjects: 55
Study: 20972736

Group type: EXPERIMENTAL
Intervention: Gliclazide plus metformin (GLIMET)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Metformin alone (MET)
Number of subjects: 47
Study: 17110073

Group type: EXPERIMENTAL
Intervention: Soy-based formulation containing pure soy standardized extract of isoflavones
Number of subjects: 12

Group type: COMPARATOR
Intervention: Soy-based formulation containing soy flour in addition to the standardized extract of isoflavones
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Equol producers
Number of subjects: 12

Group type: COMPARATOR
Intervention: Equol non-producers
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Equol producers with equol excretion added to daidzein excretion
Number of subjects: 12
Study: 15677794

Group type: EXPERIMENTAL
Intervention: Repaglinide (1 mg twice a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Glibenclamide (5 mg twice a day)
Number of subjects: 16
Study: 12448341

Group type: EXPERIMENTAL
Intervention: Polymeric diet (PD)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Polymeric diet (PD) plus zidovudine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Regular foods (RF)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups (PD and RF)
Number of subjects: 46
Study: 10437877

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg twice daily
Number of subjects: 1
Study: 8533735

Group type: EXPERIMENTAL
Intervention: Stage hypnosis show
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Public lecture on hypnosis
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 205
Study: 2270941

Group type: EXPERIMENTAL
Intervention: Human isophane insulin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lente insulin
Number of subjects: 52
Study: 7022778

Group type: EXPERIMENTAL
Intervention: Day-case surgery
Number of subjects: 138

Group type: COMPARATOR
Intervention: Inpatient surgery
Number of subjects: 138
Study: 31814522

Group type: EXPERIMENTAL
Intervention: Oral stimulation protocol (10 minutes)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 47
Study: 30704534

Group type: EXPERIMENTAL
Intervention: ProHEAD online intervention
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control condition (recommendation to seek help and online information)
Number of subjects: 1500
Study: 27761668

Group type: EXPERIMENTAL
Intervention: Extraoral infrared light therapy for 20 min daily with at least 80% compliance (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 40
Study: 26362959

Group type: EXPERIMENTAL
Intervention: Paracetamol-codeine phosphate (300 mg + 30 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Naproxen sodium-codeine phosphate (550 mg + 30 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 64
Study: 22672359

Group type: EXPERIMENTAL
Intervention: Immediate treatment group (n=14)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Delayed treatment group (n=13)
Number of subjects: 27
Study: 21720655

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1% applied twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical medical device cream applied three times daily
Number of subjects: 20
Study: 19179127

Group type: EXPERIMENTAL
Intervention: Bismuth 240 mg bis in die for 14 days combined with amoxicillin 1g plus metronidazole 250 mg tris in die for the first week
Number of subjects: 108

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once a day for 14 days combined with amoxicillin 1g plus metronidazole 250 mg tris in die for the first week
Number of subjects: 108
Study: 16838877

Group type: EXPERIMENTAL
Intervention: Xylitol candies distributed three times during the school day
Number of subjects: 145

Group type: COMPARATOR
Intervention: Xylitol candies
Number of subjects: 145
Study: 12810938

Group type: EXPERIMENTAL
Intervention: Intra-articular triamcinolone hexacetonide (TH)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Intra-articular triamcinolone acetonide (TA)
Number of subjects: 85
Study: 10709370

Group type: EXPERIMENTAL
Intervention: Counseling by a pharmacy officer
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Therapeutic interventions initiated by the pharmacy officer
Number of subjects: 43
Study: 8598434

Group type: EXPERIMENTAL
Intervention: Diet only
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Exercise only
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise
Number of subjects: 127
Study: 1390616

Group type: EXPERIMENTAL
Intervention: Rural Mexican Diet (RMD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Urban Mexican Diet (UMD)
Number of subjects: 16
Study: 3891436

Group type: EXPERIMENTAL
Intervention: Topical antihistaminics
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30122390

Group type: EXPERIMENTAL
Intervention: Dual anterior short instrumentation and fusion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Posterior pedicle screw instrumentation and fusion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 27520578

Group type: EXPERIMENTAL
Intervention: Matched learning style group (instructors taught according to students' preferred learning style)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmatched learning style group (instructors taught without regard to students' preferred learning style)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Matched learning style group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmatched learning style group
Number of subjects: 0
Study: 26372467

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 120

Group type: COMPARATOR
Intervention: Patients with asthma
Number of subjects: 120

Group type: COMPARATOR
Intervention: Patients with mild COPD
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Patients with moderate COPD
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Patients with severe COPD
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Patients with very-severe COPD
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: COPD cohort
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Asthma cohort
Number of subjects: 120
Study: 24183277

Group type: EXPERIMENTAL
Intervention: Ultrasonically activated shears (USS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional suture ligatures
Number of subjects: 40
Study: 21511454

Group type: EXPERIMENTAL
Intervention: Nurse-led menu driven intervention
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Concordance interview
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 239
Study: 19151050

Group type: EXPERIMENTAL
Intervention: Topical levobupivacaine 0.75%
Number of subjects: 246

Group type: COMPARATOR
Intervention: Topical lidocaine 2%
Number of subjects: 246
Study: 16025542

Group type: EXPERIMENTAL
Intervention: Model-based approach for estimating MTD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional 3+3 design
Number of subjects: 0
Study: 15054437

Group type: EXPERIMENTAL
Intervention: Vitamin A (VA) supplementation (210 micromol) and deworming (400 mg albendazole) in Group 1 (VA administered > or = 4 months before baseline)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: VA delivered through the public health system in Group 2 (VA administered < or = 1 month before baseline)
Number of subjects: 131
Study: 10937309

Group type: EXPERIMENTAL
Intervention: Relative pitch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direction of pitch change
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Level of pitch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory display design
Number of subjects: 0
Study: 9071556

Group type: EXPERIMENTAL
Intervention: 0.05% desonide ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2.5% hydrocortisone ointment
Number of subjects: 0
Study: 7527736

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (CAP or modified M-VAC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (modified M-VAC or MEC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no adjuvant chemotherapy)
Number of subjects: 20
Study: 2568246

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 4391702

Group type: EXPERIMENTAL
Intervention: Alprenolol 100 mg four times daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Pentanitrol 30 mg four times daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31060125

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 28688338

Group type: EXPERIMENTAL
Intervention: Pregnenolone (50 mg/day)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 26144319

Group type: EXPERIMENTAL
Intervention: Bladder-Rectum Spacer Balloon (BRSB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vaginal Gauze Packing (VGP)
Number of subjects: 80
Study: 24262299

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 23388588

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg 30 minutes before bedtime for 6 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Clonazepam 2 mg at night (with gradual titration over 4 weeks from 0.5 mg)
Number of subjects: 38
Study: 20653727

Group type: EXPERIMENTAL
Intervention: 5‐0 poliglecaprone‐25
Number of subjects: 52

Group type: COMPARATOR
Intervention: 6‐0 polypropylene
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 5‐0 poliglecaprone‐25 and 6‐0 polypropylene
Number of subjects: 52
Study: 19045977

Group type: EXPERIMENTAL
Intervention: 8-week Internet-based cognitive behavior therapy program with minimal therapist contact via e-mail and weekly telephone calls of less than 15 min
Number of subjects: 66

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 66
Study: 15949095

Group type: EXPERIMENTAL
Intervention: 0.05% solution of betamethasone dipropionate (BD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Hydrocortisone with oxytetracycline hydrochloride and polymyxin B (HCPB)
Number of subjects: 51
Study: 14627440

Group type: EXPERIMENTAL
Intervention: Isoflavones tablets
Number of subjects: 853
Study: 10571764

Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg)
Number of subjects: 60
Study: 9380298

Group type: EXPERIMENTAL
Intervention: Estrogens (0.15 or 0.3 or 0.625 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 8436494

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (100mg, two capsules a day for 15 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pressure threshold measurements
Number of subjects: 20
Study: 3296154

Group type: EXPERIMENTAL
Intervention: Lacrisert
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (saccharose crystals)
Number of subjects: 29
Study: 28913928

Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 302
Study: 27568900

Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray 1.75 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray 3.5 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray 5.0 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray (1.75 mg, 3.5 mg, 5.0 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Zolpidem nasal spray
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 25099578

Group type: EXPERIMENTAL
Intervention: Hospitals participating in the pay-for-performance program (Advancing Quality)
Number of subjects: 1825518

Group type: COMPARATOR
Intervention: Control hospitals (not participating in the program)
Number of subjects: 1825518
Study: 21735215

Group type: EXPERIMENTAL
Intervention: Fast lifting speed (1.9 s/repetition)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Slow lifting speed (5.6 s/repetition)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Medium lifting speed (2.8 s/repetition)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Ballistic maximum speed
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Heavier conditions (80% 1RM)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Lighter intensities (40% 1RM)
Number of subjects: 13
Study: 21152784

Group type: EXPERIMENTAL
Intervention: cream with Belides, Emblica and Licorice 7%, applied twice a day
Number of subjects: 56

Group type: COMPARATOR
Intervention: cream with Hydroquinone 2%, used at night
Number of subjects: 56
Study: 18777976

Group type: EXPERIMENTAL
Intervention: 12-week walking training program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outpatient clinic-based walking program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health promotion interventions
Number of subjects: 0
Study: 15941541

Group type: EXPERIMENTAL
Intervention: Fixed effect model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random effect model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covariance analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heterogeneity test (fixed effect model)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heterogeneity test (random effect model)
Number of subjects: 0